Search
Frequent Major Outbound Licensing Deals Highlight China's Innovative Drugs on the Global Stage
1 day ago /
Read about 0 minute
Author：小编
Recently, Chinese innovative pharmaceutical companies have frequently secured substantial outbound licensing deals, with notable examples being Sansheng Pharmaceutical's agreement worth over $6 billion and CSPC Pharmaceutical Group's cooperation agreement valued at $5.33 billion. These transactions not only underscore the growing global competitiveness of China's innovative drugs but also signify the transformation of China's innovative drug industry from a 'follower' to a significant 'contributor' on the world stage.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
